Ameriprise’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.3K | Sell |
23,500
-23,397
| -50% | -$21.2K | ﹤0.01% | 3908 |
|
|
2025
Q1 | $21.2K | Buy |
46,897
+4,019
| +9% | +$1.82K | ﹤0.01% | 3947 |
|
|
2024
Q4 | $21.5K | Buy |
42,878
+19,378
| +82% | +$9.74K | ﹤0.01% | 4019 |
|
|
2024
Q3 | $21.3K | Sell |
23,500
-160
| -0.7% | -$145 | ﹤0.01% | 3894 |
|
|
2024
Q2 | $23.6K | Hold |
23,660
| – | – | ﹤0.01% | 3837 |
|
|
2024
Q1 | $35K | Sell |
23,660
-2,000
| -8% | -$2.96K | ﹤0.01% | 3821 |
|
|
2023
Q4 | $28K | Hold |
25,660
| – | – | ﹤0.01% | 3866 |
|
|
2023
Q3 | $30.3K | Sell |
25,660
-14
| -0.1% | -$17 | ﹤0.01% | 3856 |
|
|
2023
Q2 | $36.2K | Hold |
25,674
| – | – | ﹤0.01% | 3874 |
|
|
2023
Q1 | $38.5K | Buy |
25,674
+14
| +0.1% | +$21 | ﹤0.01% | 3877 |
|
|
2022
Q4 | $30K | Sell |
25,660
-43,600
| -63% | -$51K | ﹤0.01% | 3878 |
|
|
2022
Q3 | $78K | Buy |
69,260
+28,600
| +70% | +$32.2K | ﹤0.01% | 3855 |
|
|
2022
Q2 | $64K | Buy |
+40,660
| New | +$64K | ﹤0.01% | 3814 |
|
|
2022
Q1 | – | Sell |
-304,989
| Closed | -$747K | – | 3988 |
|
|
2021
Q4 | $747K | Buy |
+304,989
| New | +$747K | ﹤0.01% | 3378 |
|
|
2018
Q3 | – | Sell |
-42,973
| Closed | -$78K | – | 3749 |
|
|
2018
Q2 | $78K | Sell |
42,973
-30,939
| -42% | -$56.2K | ﹤0.01% | 3571 |
|
|
2018
Q1 | $172K | Buy |
73,912
+3,469
| +5% | +$8.07K | ﹤0.01% | 3498 |
|
|
2017
Q4 | $133K | Sell |
70,443
-1,955
| -3% | -$3.69K | ﹤0.01% | 3529 |
|
|
2017
Q3 | $180K | Buy |
72,398
+20,637
| +40% | +$51.3K | ﹤0.01% | 3527 |
|
|
2017
Q2 | $142K | Buy |
+51,761
| New | +$142K | ﹤0.01% | 3610 |
|
|
2014
Q4 | – | Sell |
-9,280
| Closed | -$24K | – | 4093 |
|
|
2014
Q3 | $24K | Buy |
9,280
+8,896
| +2,317% | +$23K | ﹤0.01% | 4379 |
|
|
2014
Q2 | $1K | Buy |
+384
| New | +$1K | ﹤0.01% | 5324 |
|
|
2013
Q4 | – | Sell |
-2,852
| Closed | -$9K | – | 5281 |
|
|
2013
Q3 | $9K | Hold |
2,852
| – | – | ﹤0.01% | 4972 |
|
|
2013
Q2 | $9K | Buy |
+2,852
| New | +$9K | ﹤0.01% | 4847 |
|